Replies to post #252460 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Your assumption that IPIX will pay is dead wrong"

I don't remember making that assumption. I DO remember asking these questions...
"How much do you think the B-OM Phase 3 will cost? Will they need the current facility to conduct it? "
...and I'm still curious about the answers, even if a license agreement renders them moot.


"unless Leo fails to license OM, then we are all pretty much out of business."
Is that really the only way that IPIX can survive?

I don't think so. The alternatives may not be pleasant but they exist. Of course pursuing them without being certain that Brilacidin isn't a sure thing for SOME indication would be foolhardy because they would be expensive. There's always money laying around, just ask the MFO.

[zandant]

It's time to face reality. If BP were interested in B or any platform IPIX had to offer, they would have moved in by now. BP certainly has a better view than we do of any value B might have. Don't you think if they equated B with millions or billions they would have swooped in by now? The fantasy is over. We lost all of our money thanks in part to an incompetent CEO and a failed platform that was not as promising as the company led us to believe.

[frrol]

Yes, the deal would very likely cover all B costs for whatever indications the licenses are for (OM and IBD as far as we know). There's no choice in that matter, and is typical anyway in deals where the licensor is not well capitalized.